𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytogenetics in acute myeloid leukaemia

✍ Scribed by H Walker; F.J Smith; D.R Betts


Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
985 KB
Volume
8
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Colonic obstruction in acute myeloid leu
✍ P. Karatsis; M. Farouk; A. Wyman; H. M. Sweetland; Professor K. Rogers πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 142 KB
TdT expression in acute myeloid leukaemi
✍ Stark, A. N. ;MacKarill, I. D. ;Limbert, H. J. ;Evans, P. ;Scott, C. S. πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag βš– 486 KB

A total of 412 cases of acute leukaemia were examined for the presence of nuclear terminal deoxynucleotidyl transferase (TdT) by indirect immunofluorescence. Of the 129 cases of acute myeloblastic leukaemia (AML FAB groups M1/M2) examined, 18% (n = 23) had significant proportions (greater than 10%)

Chromosome banding anomalies in acute my
✍ TamΓ‘s Fleischmann; Ferenc Bodor πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 French βš– 290 KB

## Abstract Chromosome analysis in two cases of acute myeloid leukaemia are reported. On the basis of slight aberrations in the banding pattern marker chromosomes were observed in both cases. In one case a widened C‐band of an additional D chromosome, and in the other case an unusual negative fluor

Relevance of clinical trials in acute my
✍ Apostolia M. Tsimberidou; Elihu Estey πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 57 KB

## Abstract Patients with newly diagnosed acute myeloid leukaemia (AML) are increasingly being enrolled in clinical trials sponsored by pharmaceutical companies or the National Cancer Institute. These trials routinely exclude patients who are less likely to respond (LLTR), e.g. those with Zubrod pe